DARTMOUTH-HITCHCOCK MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1983-01-01
- Employees
- 10K
- Market Cap
- -
Clinical Trials
462
Active:13
Completed:306
Trial Phases
6 Phases
Early Phase 1:11
Phase 1:36
Phase 2:46
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (372 trials with phase data)• Click on a phase to view related trials
Not Applicable
254 (68.3%)Phase 2
46 (12.4%)Phase 1
36 (9.7%)Phase 4
19 (5.1%)Early Phase 1
11 (3.0%)Phase 3
6 (1.6%)Enabling Self-Care for Pessary Users in Rural Setting
Not Applicable
Not yet recruiting
- Conditions
- Pelvic Organ Prolapse
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT07084818
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerAdjuvant TreatmentEarly Stage Breast Cancer
- Interventions
- Drug: SwitchOther: Guideline Directed Intervention (GDI)
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 62
- Registration Number
- NCT07071038
- Locations
- 🇺🇸
Dartmouth Cancer Center, Lebanon, New Hampshire, United States
Phase 1 ABY-029 Glioma Clinical Trial
- First Posted Date
- 2025-07-14
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT07063693
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
Not Applicable
Not yet recruiting
- Conditions
- Pancreas Adenocarcinoma
- Interventions
- Drug: modified FOLFIRINOX (mFOLFIRINOX)
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 35
- Registration Number
- NCT07043270
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
24GUT540 : Meeting of Breast Cancer Patients and Pathologists
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT07040514
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 93
- Next
News
AI Revolutionizes Cancer Detection: Breakthroughs in Liquid Biopsies, Imaging, and Pathology
Advanced machine learning algorithms enable liquid biopsies for early lung cancer detection, potentially increasing annual lives saved from 600 to 12,000 in the United States through blood-based screening.